Assignee
SHIFA BIOMEDICAL CORP
US·6 granted patents·2 pending applications·18 citations·filing 2014–2020
Top patents by PatentIndex Score
8 records- 0190US10947220B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2020·Granted Mar 16, 2021·2 cites·7 claims
- 0290US10131637B2Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Nov 20, 2018·10 cites·6 claims
- 0385US9682085B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Jun 20, 2017·4 cites·5 claims
- 0478US10899748B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Granted Jan 26, 2021·2 cites·5 claims
- 0556US12274693B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation of compounds and methods of using the sameSHIFA BIOMEDICAL CORP·Filed 2019·Granted Apr 15, 2025·0 cites·30 claims
- 0655US2018079730A1Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 0742US2016256467A1Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2016·Application pending·0 cites
- 0837US10259804B2Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2015·Granted Apr 16, 2019·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →